GetTopicDetailResponse(id=d071591950d, topicName=日光性角化病, introduction=日光性角化病, content=null, image=null, comments=1, allHits=1033, url=https://h5.medsci.cn/topic?id=59195, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=57472, tagList=[TagDto(tagId=57472, tagName=日光性角化病)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2262296, encodeId=9e702262296fe, content=<a href='/topic/show?id=6ef6645e09e' target=_blank style='color:#2F92EE;'>#治療#</a> <a href='/topic/show?id=d071591950d' target=_blank style='color:#2F92EE;'>#日光性角化病#</a>, objectTitle=日光性角化病治療研究進展, objectType=article, longId=873512, objectId=d6068e3512ca, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021554762_4754896.jpeg, objectUrl=/article/show_article.do?id=d6068e3512ca, replyNumber=0, likeNumber=39, createdTime=2025-04-26, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=d6068e3512ca, moduleTitle=日光性角化病治療研究進展, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d6068e3512ca)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2249486, encodeId=e08b2249486ec, content=<a href='/topic/show?id=d071591950d' target=_blank style='color:#2F92EE;'>#日光性角化病#</a>影響ALA-PDT對AK療效的因素仍不清楚。部分病例報道顯示KIN Ⅲ級的AK病灶更易對ALA-PDT出現(xiàn)治療抵抗或在治療后復發(fā)。, objectTitle=【論著】| 5-氨基酮戊酸光動力治療Olsen 3級日光性角化病的療效評估及影響因素分析, objectType=article, longId=860772, objectId=4bc6860e72cc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250123/1737595810846_8538692.jpg, objectUrl=/article/show_article.do?id=4bc6860e72cc, replyNumber=0, likeNumber=33, createdTime=2025-01-24, rootId=0, userName=ms4000001513304915, userId=a1646442901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=廣東省, moduleDTOList=[ModuleDTO(moduleId=4bc6860e72cc, moduleTitle=【論著】| 5-氨基酮戊酸光動力治療Olsen 3級日光性角化病的療效評估及影響因素分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4bc6860e72cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2249321, encodeId=45a92249321b5, content=<a href='/topic/show?id=d071591950d' target=_blank style='color:#2F92EE;'>#日光性角化病#</a> <a href='/topic/show?id=64e212362081' target=_blank style='color:#2F92EE;'>#Olsen分級#</a> <a href='/topic/show?id=89651236212d' target=_blank style='color:#2F92EE;'>#5-氨基酮戊酸#</a>, objectTitle=【論著】| 5-氨基酮戊酸光動力治療Olsen 3級日光性角化病的療效評估及影響因素分析, objectType=article, longId=860772, objectId=4bc6860e72cc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250123/1737595810846_8538692.jpg, objectUrl=/article/show_article.do?id=4bc6860e72cc, replyNumber=0, likeNumber=30, createdTime=2025-01-23, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=4bc6860e72cc, moduleTitle=【論著】| 5-氨基酮戊酸光動力治療Olsen 3級日光性角化病的療效評估及影響因素分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4bc6860e72cc)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2171142, encodeId=e48721e11426c, content=<a href='/topic/show?id=d071591950d' target=_blank style='color:#2F92EE;'>#日光性角化病#</a> <a href='/topic/show?id=d45f10e8825b' target=_blank style='color:#2F92EE;'>#皮膚系統(tǒng)#</a> <a href='/topic/show?id=f33b10e883cf' target=_blank style='color:#2F92EE;'>#表皮內瘤#</a>, objectTitle=WHO圖文精簡筆記 || ?日光性角化病, objectType=article, longId=802244, objectId=21e08022447c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/conference-with-doctors-in-medical-aprons-PT29AAG.jpg, objectUrl=/article/show_article.do?id=21e08022447c, replyNumber=0, likeNumber=81, createdTime=2023-11-26, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21e08022447c, moduleTitle=WHO圖文精簡筆記 || ?日光性角化病, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=21e08022447c)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
前往app查看評論內容
#日光性角化病#影響ALA-PDT對AK療效的因素仍不清楚。部分病例報道顯示KIN Ⅲ級的AK病灶更易對ALA-PDT出現(xiàn)治療抵抗或在治療后復發(fā)。
